PRPH2 p.Pro313Leu
c.938C>T · rs61748434 · VCV98721
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| REVEL | 0.036 | moderately benign-leaning |
|---|---|---|
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 3.5 | GERP 0.32, phastCons 0.94 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 24 kb · p 0.64 · regional, not allelic |
| Overall | ||
| CADD | 15.8 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0896% | 1,116 |
| European (non-Finnish)grpmax | 0.0848% | 1,179 |
| South Asian | 0.0714% | 1,401 |
| African / African-American | 0.0293% | 3,410 |
| Admixed American | 0.0183% | 5,455 |
| Middle Eastern | 0.0165% | 6,062 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PRPH2
- Protein
- p.Pro313Leu
- Coding
- c.938C>T
- MANE Select
- NM_000322
- dbSNP
- rs61748434
- Type
- single nucleotide variant
- Location
- chr6:42698398 (GRCh38)
- Gene constraint
- LOEUF 0.773 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 87.56 · 1 PDB
- Residue 313
- a UniProt-annotated variant site (in)
Disease context
PRPH2-related disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: fundus albipunctatuspatterned macular dystrophy 1adult-onset foveomacular vitelliform dystrophychoroidal dystrophy, central areolar 2cone-rod dystrophypatterned dystrophy of the retinal pigment epitheliuminherited retinal dystrophyretinitis pigmentosaStargardt disease
Similar variants
- PRPH2 p.Pro313Ser Uncertain significance ★★ same residue
- PRPH2 p.Pro313Gln Uncertain significance ★ same residue
- PRPH2 p.Pro313= Likely benign ★ same residue
- PRPH2 p.Pro313fs Pathogenic ★ same residue
- PRPH2 c.581+1G>A Pathogenic ★★ same condition
- PRPH2 c.582-1G>A Pathogenic/Likely pathogenic ★★ same condition
- PRPH2 c.582-2A>T Pathogenic ★★ same condition
- PRPH2 c.828+1G>A Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prph2-p-pro313leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown